Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study

作者：Raj Makkar, Vinod H. Thourani, Torsten Vahl, Pradeep Kumar Yadav, James M. McCabe, Isaac George, Lowell F. Satler, Stan Chetcuti, David Daniels, Thomas Waggoner, Brian Whisenant, Mark Russo, Matthew J. Summers, Santiago Garcia, Tiberio Frisoli, Ravi K Ramana, Curtiss Stinis, Harsh Golwala, Firas Zahr, Adam B. Greenbaum, Joshua D. Rovin, Carlos Sanchez, Molly Szerlip, George Deeb, Nicholas Amoroso, Dhairya Patel, Martin Fahy, Lauren S. Ranard, Aakriti Gupta, Tarun Chakravarty, Sabah Skaf, Michael L. Chuang, Susheel Kodali, Hans R Figulla, Hendrik Treede, Stephan Baldus, Duane S. Pinto, Martin B Leon, Gabriel Aldea, Vasilis Babaliaros, Stephen Bailey, Steven R Bailey, Andrea Carpenter, Wen Chen, Mark J Gorman, Katherine Harrington, Samir Kapadia, Tsuyoshi Kaneko, Clinton Kemp, Dean Kereiakes, Ramzi Khalil, Amar Krishnaswamy, Basel Ramlawi, Michael Reardon, Vivek Rajagopal, Newell B Robinson, Paul Sorraja, Brett C Sheridan, Richard Smalling, Antone Tatooles, Jan GP Tijssen, FWA Verheught, W Douglas Weaver, Ronald Waksman, Stephen Yakubov, Alan Zajarias · 发表于：The Lancet · 年份：2025 · DOI：10.1016/s0140-6736(25)02215-9 · 被引用次数：12 · 研究领域：Cardiac Valve Diseases and Treatments、Aortic Disease and Treatment Approaches、Congenital Heart Disease Studies